Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAccess to the study record page now shows a 403 Forbidden error, replacing the expected content. This indicates the record is currently inaccessible.SummaryDifference19%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedThe study record now lists NIH grant/contract notes for 2019 and 2023. The page shows an updated revision tag, Revision: v3.6.6.SummaryDifference0.1%

- Check36 days agoChange DetectedNo textual changes were provided in the change data, so the page content remains unchanged based on the input.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.6.5 is now displayed on the page, replacing the prior version. This indicates a minor, system-level update to the page rather than a substantive change to the study details or user-facing content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page now shows revision v3.6.4, reflecting a minor internal update to the ClinicalTrials.gov interface. No study data, eligibility criteria, or results content were changed.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision: v3.6.3 replaces v3.6.2 on the page, signaling a small update to the page's version history rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.